- Home
- JMSB vs FHTX Comparison
JMSB vs FHTX Comparison
Compare JMSB & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JMSB | FHTX |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 308.2M | 360.5M |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | JMSB | FHTX |
|---|---|---|
| Price | $23.25 | $6.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $23.00 | $11.50 |
| AVG Volume (30 Days) | 29.9K | ★ 214.5K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.72% | N/A |
| EPS Growth | 24.17 | ★ 25.32 |
| EPS | ★ 0.93 | N/A |
| Revenue | N/A | ★ $30,909,000.00 |
| Revenue This Year | $17.09 | $8.89 |
| Revenue Next Year | $10.03 | $20.13 |
| P/E Ratio | $25.01 | ★ N/A |
| Revenue Growth | N/A | ★ 36.75 |
| 52 Week Low | $18.50 | $3.27 |
| 52 Week High | $24.26 | $6.95 |
Technical Indicators
Market Signals| Indicator | JMSB | FHTX |
|---|---|---|
| Relative Strength Index (RSI) | 57.10 | 63.88 |
| Support Level | $20.72 | $4.37 |
| Resistance Level | $24.26 | $6.76 |
| Average True Range (ATR) | 0.57 | 0.42 |
| MACD | -0.05 | 0.14 |
| Stochastic Oscillator | 48.69 | 75.46 |
Price Performance
Historical ComparisonAbout JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.